×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NVCT – nuvectis pharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NVCT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/10
08:14 am
nvct
Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium [Yahoo! Finance]
Low
Report
Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium [Yahoo! Finance]
12/10
08:00 am
nvct
Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium
Low
Report
Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium
11/25
11:40 am
nvct
Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? [Yahoo! Finance]
Low
Report
Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? [Yahoo! Finance]
11/14
02:35 pm
nvct
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug [Yahoo! Finance]
Medium
Report
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug [Yahoo! Finance]
11/14
07:09 am
nvct
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer [Yahoo! Finance]
High
Report
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer [Yahoo! Finance]
11/14
07:00 am
nvct
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer
High
Report
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer
11/5
10:30 am
nvct
Nuvectis Pharma GAAP EPS of -$0.24 beats by $0.01 [Seeking Alpha]
High
Report
Nuvectis Pharma GAAP EPS of -$0.24 beats by $0.01 [Seeking Alpha]
11/5
07:00 am
nvct
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
High
Report
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/16
05:38 pm
nvct
Form 4/A Nuvectis Pharma, Inc. For: Dec 12 Filed by: Mosseri Marlio Charles
Medium
Report
Form 4/A Nuvectis Pharma, Inc. For: Dec 12 Filed by: Mosseri Marlio Charles
12/16
08:00 am
nvct
Form 4 Nuvectis Pharma, Inc. For: Dec 13 Filed by: Mosseri Marlio Charles
Low
Report
Form 4 Nuvectis Pharma, Inc. For: Dec 13 Filed by: Mosseri Marlio Charles
11/20
08:30 am
nvct
Form 4 Nuvectis Pharma, Inc. For: Nov 19 Filed by: Poradosu Enrique
Medium
Report
Form 4 Nuvectis Pharma, Inc. For: Nov 19 Filed by: Poradosu Enrique
11/18
08:30 am
nvct
Form 4 Nuvectis Pharma, Inc. For: Nov 15 Filed by: BENTSUR RON
Low
Report
Form 4 Nuvectis Pharma, Inc. For: Nov 15 Filed by: BENTSUR RON
11/8
03:59 pm
nvct
Form 4 Nuvectis Pharma, Inc. For: Jan 03 Filed by: Carson Michael J.
Low
Report
Form 4 Nuvectis Pharma, Inc. For: Jan 03 Filed by: Carson Michael J.
11/5
10:55 am
nvct
Form SC 13G/A Nuvectis Pharma, Inc. Filed by: Pontifax Management 4 G.P. (2015) Ltd.
High
Report
Form SC 13G/A Nuvectis Pharma, Inc. Filed by: Pontifax Management 4 G.P. (2015) Ltd.
11/5
08:32 am
nvct
Form 10-Q Nuvectis Pharma, Inc. For: Sep 30
High
Report
Form 10-Q Nuvectis Pharma, Inc. For: Sep 30
11/5
07:09 am
nvct
Form 8-K Nuvectis Pharma, Inc. For: Nov 05
High
Report
Form 8-K Nuvectis Pharma, Inc. For: Nov 05
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: